Intrinsic Value of S&P & Nasdaq Contact Us

Intra-Cellular Therapies, Inc. ITCI NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$132.00
+0.1%

Intra-Cellular Therapies, Inc. (ITCI) has 12 identified peers for comparison in the Healthcare sector. Peers include ALKS, AMPH, AMRX, ANIP, AQST, COLL and others.

ITCI has a market capitalization of $14.05B, compared to an average peer market cap of $2.66B. ITCI is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message